Transfer of marker genes into hemopoietic progenitor cells

Cytokines and Molecular Therapy

Volumn 2, Issue 3, 1996, Pages 193-200

  Brenner, Malcolm K ^a   Heslop, Helen E ^a   Rill, Donna ^b   Li, Congfen ^c   Smith, Colton ^a   Krance, Robert ^a   Rooney, Cliona ^a   Brenner, Malcolm ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b Department of Pediatrics ^*  (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Gene transfer; Hemopoietic cells; Marker genes; Marrow; Neomycin phosphotransferase; Stem cell transplantation; T lymphocytes

Indexed keywords

CELL MARKER; CYTOKINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; BONE MARROW CELL; BONE MARROW PURGING; CANCER RECURRENCE; CELL CLONE; CELL POPULATION; CONFERENCE PAPER; GENE EXPRESSION; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; MARKER GENE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL;

BONE MARROW CELLS; BONE MARROW PURGING; BONE MARROW TRANSPLANTATION; GENE TRANSFER TECHNIQUES; GENETIC MARKERS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; NEOPLASMS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029806193     PISSN: 13556568     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (40)

1. Andersen WF, Human gene therapy. Science (1992) 256:808-13.
2. Miller AD, Human gene therapy comes of age. Nature (1992) 357: 455-60.
3. Hughes PFD, Thacker JD, Hogge D et al, Retroviral gene transfer to primitive normal and leukemic hematopoietic cells using clinically applicable procedures. J Clin Invest (1992) 89: 1817-24.
4. Smith C, Retroviral vector-mediated gene transfer into hematopoietic cells: prospects and issues. 3 Hematother (1992) 1: 155-66.
5. Schuening FG, Kawahara K, Miller AD et al, Retrovirus-mediated gene transduction into longterm repopulating marrow cells of dogs. Blood (1991) 78:2568-76.
6. Van Beusechem VW, Kukler A, Heidt PJ, Valerio D, Long-term expression of human adenosine deaminase in rhesus monkeys transplanted with retrovirusinfected bone-marrow cells. Proc Natl Acad Sei USA (1992) 89: 7640-4.
7. Rill DR, Moen RC, Buschle M et al, An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirusmediated gene transfer. Blood (1992) 79: 2694-700.
8. Wieder R, Cornetta K, Kessler SW, Anderson WF, Increased efficiency of retrovirus-mediated gene transfer and expression in primate bone marrow progenitors after 5-fluorouracil-induced hematopoietic suppression and recovery. Blood (1991) 77: 448-55.
9. Otsuka T, Thacker JD, Eaves CJ, Hogge DE, Differential effects of microenvironmentally presented interleukin 3 versus soluble growth factor on primitive human hematopoietic cells. 3 Clin Invest (1991) 88: 417-22.
10. Otsuka T, Thacker JD, Hogge DE, The effects of interleukin 6 and interleukin 3 on early hematopoietic events in long-term cultures of human marrow. Exp Hematol (1991) 19: 1042-8.
11. Dick JE, Kamel-Reid S, Murdoch B, Doedens M, Gene transfer into normal human hematopoietic cells using in vivo and in vivo assays. Blood (1991) 78: 624-34.
12. Cornetta K, Morgan RA, Anderson WF, Safety issues related to retrovirus-mediated gene transfer in humans. Hum Gene 77zer(1991) 2: 5-14.
13. Rill DR, Buschle M,s Foreman NK et al, Retro virus mediated gene transfer as an approach to analyze neuroblastoma relapse after autologous bone marrow transplantation. Hum Gene T/ier (1992) 3: 129-36.
14. Brenner MK, Rill DR, Moen RC et al, Gene-marking to trace origin of relapse after autologous bone marrow transplantation. Lancet (1993) 341: 85-6.
15. Appelbaum FR, Buckner CD, Overview of the clinical relevance of autologous bone marrow transplantation. Clin Haematol (1986) 15: 1-18.
16. Burnett AK, Tansey P, Watkins R et al, Transplantation of unpurged autologous bonemarrow in acute myeloid laukaemia in first remission. Lancet (1984) 2: 1068-70.
17. Goldstone AH, Anderson CC, Linch DC et al, Autologous bone marrow transplantation following high dose chemotherapy for the treatment of adult patients with acute myeloid leukaemia. Br J Haematol (1986) 64: 529-37.
18. Brugger W, Bross KJ, Glatt M et al, Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood (1994) 83: 636-40.
19. De Fabritiis P, Ferrero D, Sandrelli A et al, Monoclonal antibody purging and autologous bone marrow transplantation in acute myelogenous leukemia in complete remission. Bone Marrow Transplant (1989) 4: 669-74.
20. Gorin NC, Douay L, Laporte JP et al, Autologous bone marrow transplantation using marrow incubated with Asta Z 7557 in adult acute leukemia. Blood (1986) 67: 1367-76.
21. Gambacorti-Passerini C, Rivoltini L, Fizzotti M et al, Selective purging by human interleukin-2 activated lymphocytes of bone marrows contaminated with a lymphoma line or autologous leukaemic cells. Br J Haematol (1991) 78: 197-205.
22. Santos GW, Yeager AM, Jones RJ, Autologous bone marrow transplantation. Annu Rev Med (1989) 40: 99-112.
23. Gribben JG, Freedman AS, Neuberg .D et al, Immunologie purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl jf Med (1991) 325: 1525-33.
24. Yeager AM, Kaizer H, Santos GW et al, Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. N EngljfMed(l986) 315: 141-7.
25. Campana D, Coustan-Smith E, Behm FG, The définition of remission in acute leukemia with immunological techniques. Bone Marrow Transplant (1991) 8: 429-37.
26. Uckun FM, Kersey JH, Haake R et al, Pretransplantation burden of leukemic progenitor cells as a predictor of relapse after bone marrow transplantation for acute lymphoblastic leukemia. N EnglJ Aff (1993) 329: 1296-301.
27. Kaizer H, Stuart RK, Brookmeyer R et al, Autologous bone marrow transplantation in acute leukemia: a phase I study of in vitro treatment of marrow with 4hydroperoxycyclophosphamide to purge tumor cells. 5/0orf(1985) 65: 1504-1510.
28. Miyoshi H, Shimizu K, Kozu T et al, t(8; 21) Breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. Proc Natl Acad Sei USA (1991) 88: 10431-5.
29. Erickson P, Gao J, Chang et al, Identification of breakpoints in t(8; 21) AML and isolation of a fusion transcript with similarity to Drosophila segmentation gene runt. Blood (1992) 80: 1825-31.
30. Nucifora G, Birn DJ, Erickson P et al, Detection of DNA rearrangements in the AML1 and ETO loci and of an AML1/ETO fusion mRNA in patients with t(8; 21) acute myeloid leukemia. Blood (1993) 81: 883-8.
31. Rill DR, Santana VM, Roberts WM et al, Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. 5/ooJ(1994) 84: 380-3.
32. Deisseroth AB, Zu Z, Claxton D et al, Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogenous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood (1994) 83: 3068-76.
33. Dunbar CE, Cottier-Fox M, O'Shaunessy JA et al, Retrovirally marked CD34-enriched peripheral blood and marrow cells contribute to long term engraftment after autologous transplantation. Blood (1995) 85: 3048-57.
34. Brenner MK, Rill DR, Holladay MS et al, Gene marking to determine whether autologous marrow infusion restores long-term haemopoiesis in cancer patients. Lancet (1993) 342: 1134-7.
35. Ochman HA, Gerber S, Hart DL, Genetic application of an inverse polymerase chain reaction. Genetics (1988) 120:621-3.
36. Donahue RE, Kessler SW, Bodine D et al, Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med(l992) 176: 1125-35.
37. Straus SE, Cohen JI, Tosato G, Meier J, Epstein-Barr virus infections: biology, pathogenesis and management. Ann Intern Med (1992) 118: 45-58.
38. Papadopoulos EB, Ladanyi M, Emanuel D et al, Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 330: 1185-91.
39. Heslop HE, Ng CY, Li CF et al, Long term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene modified virus-specific T lymphocytes. Nature Medicine (1996) 2: 551-5.
40. Rosenberg SA, The immunotherapy and gene therapy of cancer. J Clin Oco/(1992) 10: 180-99.